Answer a few questions to get a personalized, evidence-informed estimate of how UAE is likely to help your symptoms.
Based on published research. These are population-level, evidence-informed estimates — not a validated clinical prediction model. Individual outcomes depend on MRI findings and physician evaluation.
Diagnosis, age group, main symptom, fibroid size, fibroid location, adenomyosis pattern, MRI signal characteristics, and prior myomectomy history — per published UAE outcome predictors.
Spies JB et al. Disease-specific symptom and health-related quality of life questionnaire for leiomyomata. Obstet Gynecol. 2002. (Symptom domains used as conceptual basis.)
Tropeano G et al. Clinical failure predictors after UAE. Hum Reprod. 2014.
Kurban D et al. MRI predictors of UAE volumetric response. Diagn Interv Radiol. 2019.
Llewellyn CM et al. Giant fibroid meta-analysis. JVIR. 2022.
Davis MR et al. 5-year reintervention after UAE. J Womens Health. 2018.
Manyonda IT et al. FEMME trial. NEJM Evid. 2023.
SIR Standards of Practice. UAE for Uterine Fibroids. JVIR. 2023.
Anchan RM et al. COMPARE-UF. Am J Obstet Gynecol. 2021.
This is an evidence-informed estimation tool, not a validated clinical prediction model. Numbers are derived from published ranges, not individual regression coefficients.
Bring your MRI or ultrasound report to a UAE consultation. An interventional radiologist can review your imaging and give you a personalized assessment.